RESUMO
OBJECTIVES: In 1984, nearly 500,000 inhabitants of Bhopal city, India, were exposed to toxic gases that leaked from a nearby pesticide manufacturing plant. In 1985, four cohorts were established to assess the long-term health impact of exposure, namely, mild, moderate, severely exposed and unexposed groups. The self-reported morbidity data of these cohorts were collected by follow-up cross-sectional surveys at regular intervals over the last 35 years. The present study aimed to analyse the long-term trend of chronic (duration of symptoms >3 months) respiratory morbidity in the four cohorts, stratified by age groups. STUDY DESIGN: The design of this study is a longitudinal analysis of cross-sectional respiratory morbidity data. METHODS: Chronic respiratory morbidity data within the cohorts were analysed at 5-year intervals (first recorded data from 1986). Based on age at the time of exposure, subjects were stratified into four age groups: children (aged <10 years), teenagers (aged ≥10 to <20 years), younger adults (aged ≥20 to <40 years) and older adults (aged ≥40 years). RESULTS: During the first decade, after exposure to the toxic gases, chronic respiratory morbidity in children and teenagers was high (up to 9.1%), which declined thereafter. Progressively increasing chronic respiratory morbidity was observed in both the younger and older adult age groups within all cohorts during the initial 5-10 years after exposure. Respiratory morbidity in both the younger and older adult age groups remained high for 15-20 years and thereafter recorded a declining trend. The highest respiratory morbidity observed during this study in the younger and older adult age groups was 38.6% and 59.5%, respectively; these values were both recorded in the severely exposed cohort. CONCLUSIONS: Exposure to toxic gases released during the Bhopal gas disaster has resulted in chronic respiratory morbidity of the exposed population; this morbidity has continued over decades. The age of the individuals at the time of exposure and exposure severity were crucial determinants of the long-term trend of respiratory morbidity.
Assuntos
Vazamento Acidental em Bhopal , Exposição Ambiental/efeitos adversos , Gases/efeitos adversos , Doenças Respiratórias/induzido quimicamente , Doenças Respiratórias/mortalidade , Adolescente , Adulto , Criança , Estudos Transversais , Desastres/estatística & dados numéricos , Exposição Ambiental/estatística & dados numéricos , Feminino , Intoxicação por Gás/epidemiologia , Humanos , Índia/epidemiologia , Isocianatos/intoxicação , Estudos Longitudinais , Masculino , Pessoa de Meia-Idade , Morbidade , Inquéritos e Questionários , Fatores de Tempo , Adulto JovemRESUMO
The objective was to investigate the cellular effect and action mechanism of Artemisia capillaris extract (ACE) and its component, scopoletin, on penile corpus cavernosum smooth muscle (PCCSM). In vitro study with PCCSM, the precontracted PCCSM with phenylephrine was treated with ACE or scopoletin. Cyclic nucleotides in the perfusate were measured by radioimmunoassay and expression of protein and mRNA of endothelial nitric oxide synthase (eNOS) and neuronal nitric oxide synthase in the perfused PCCSM were measured by western blot and real-time PCR, respectively. The interaction of ACE or scopoletin with udenafil was also evaluated. ACE and scopoletin exerted a significant and concentration-dependent relaxation in PCCSM. The perfusion with ACE or scopoletin significantly increased cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) and the perfusion with ACE or scopoletin increased the expression of eNOS mRNA and protein. Furthermore, ACE or scopoletin enhanced udenafil-inducing relaxation in PCCSM. ACE and scopoletin relaxed the PCCSM mainly by activating nitric oxide-cGMP system and cAMP pathway and they may be additive therapeutic candidates for ED patients who do not completely respond to udenafil.
Assuntos
Artemisia/química , Relaxamento Muscular/efeitos dos fármacos , Músculo Liso/efeitos dos fármacos , Pênis/efeitos dos fármacos , Extratos Vegetais/farmacologia , Escopoletina/farmacologia , Animais , Western Blotting , AMP Cíclico/análise , GMP Cíclico/análise , Interações Medicamentosas , Masculino , Óxido Nítrico Sintase Tipo I/genética , Óxido Nítrico Sintase Tipo III/análise , Inibidores da Fosfodiesterase 5/farmacologia , Pirimidinas/farmacologia , RNA Mensageiro/análise , Coelhos , Reação em Cadeia da Polimerase em Tempo Real , Sulfonamidas/farmacologiaRESUMO
The uncertainties associated with the measurement of the radiation output from a superficial x-ray unit are increased when using small applicators, as discussed in the text. The method described here uses two stages to measure the relative outputs: the first stage uses a large-diameter flat chamber to measure the radiation integrated over the applicator end, and the second stage uses an optical imaging system to investigate the shape of the beam. These are combined to produce a relative output for each applicator, which may then be transformed to an absolute output by applying the relative factors to a direct measurement of absolute output on one of the larger applicators.